Neuropilin-1

Neuropilin-1 분자 정보

영어 이름Neuropilin-1시판 약물 수0
임상 약물 수1표적 별명BDCA4,NP1,Neuropilin-1,NRP1,CD304,VEGF165R,Neuropilin 1,Vascular Endothelial Cell Growth Factor 165 Receptor,NRP,Transmembrane Receptor,CD304 Antigen
최고 연구 개발 단계Phase 2 Clinical
영어 이름Neuropilin-1
표적 별명BDCA4,NP1,Neuropilin-1,NRP1,CD304,VEGF165R,Neuropilin 1,Vascular Endothelial Cell Growth Factor 165 Receptor,NRP,Transmembrane Receptor,CD304 Antigen
시판 약물 수0
임상 약물 수1
최고 연구 개발 단계Phase 2 Clinical

Neuropilin-1 제품 목록

  • 속성

    Protein (5)

  • 제품 라이브러리

    온라인 (5)

  • Human (3)Mouse (2)

  • 태그

    His Tag (2)Fc Tag (1)His Tag & Avi Tag (1)Mouse IgG Fc Tag (1)

  • 마커

    Unconjugated (4)Biotin-labeled (1)

Neuropilin-1분자 배경

Neuropilin-1 (NRP1) is also known as Vascular endothelial cell growth factor 165 receptor (VEGF165R), CD antigen CD304, which belongs to the neuropilin family. The membrane-bound isoform 1 is a receptor involved in the development of the cardiovascular system, in angiogenesis, in the formation of certain neuronal circuits and in organogenesis outside the nervous system. It mediates the chemorepulsant activity of semaphorins. It binds to semaphorin 3A, The PLGF-2 isoform of PGF, The VEGF-165 isoform of VEGF and VEGF-B. Coexpression with KDR results in increased VEGF-165 binding to KDR as well as increased chemotaxis. It may regulate VEGF-induced angiogenesis. The soluble isoform 2 binds VEGF-165 and appears to inhibit its binding to cells.

Neuropilin-1분자 별명

NRP1,Neuropilin-1,NRP,VEGF165R,CD304

임상 약물 정보

영어 이름연구 코드연구 개발 단계회사적응증임상 시험
CertepetideCEND-1; iRGD; CIND-1; LSTA1; QLC12102; LSTA-1Phase 2 ClinicalDrugcendr IncAppendiceal Neoplasms; Bile Duct Neoplasms; Carcinoma, Ovarian Epithelial; Carcinoma, Pancreatic Ductal; Cholangiocarcinoma; Colonic Neoplasms; Colorectal Neoplasms; Gallbladder Neoplasms; Neoplasm Metastasis; Pancreatic Neoplasms; Triple Negative Breast Neoplasms
상세
  • 분자 정보
  • 제품 목록
  • 임상 약물 정보
문의하기

전화
글로벌: +1 800-810-0816 (무료)
아시아태평양: +86 400-682-2521

주소 서울특별시 송파구 법원로11길 11, 제3층 제비-314,315호